|
000
| 01884nam 2200373zi 4500 |
|---|
| 001 | 9.883227 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107170515 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 191231t20202020onc ob f|0| 0 eng d |
|---|
| 020 | |a9780660336589 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-342/2020E-PDF |
|---|
| 245 | 10|aAnnex 3B to the good manufacturing practices guide : |bpositron-emitting radiopharmaceuticals (GUI-0071). |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (34 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Annexe 3B aux Lignes directrices sur les Bonnes pratiques de fabrication : produits radiopharmaceutiques émetteurs de positrons. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |a"September 15, 2020." |
|---|
| 500 | |a"Replaces: Annex to the Good Manufacturing Practices Guidelines Good Manufacturing Practices (GMP) for Positron Emitting Radiopharmaceuticals (PERs) (GUI-0071), February 15, 2006." |
|---|
| 504 | |aIncludes bibliographical references (pages 33-34). |
|---|
| 650 | 0|aDrug factories|zCanada. |
|---|
| 650 | 0|aRadiopharmaceuticals|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tAnnexe 3B aux Lignes directrices sur les bonnes pratiques de fabrication : |w(CaOODSP)9.883229 |
|---|
| 856 | 40|qPDF|s1.45 MB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H14-342-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-manufacturing-practices-positiron-emitting-radiopharmaceuticals/document.html |
|---|